Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Montserrat E et al. – Genetic abnormalities provide important clues in understanding the clinical and biologic heterogeneity of CLL, assessing the individual risk of each patient with this form of leukemia and also predicting response to therapy.

Related Articles

AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations
Modern Pathology, 11/11/09    Relevance Score: 82%

Evidence of serum immunoglobulin abnormalities up to 9.8 years prior to diagnosis of chronic lymphocytic leukemia: A prospective study
Blood, 10/30/09    Relevance Score: 81%

Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells
Haematologica, 10/13/09    Relevance Score: 81%

Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09    Relevance Score: 81%

Chronic lymphocytic leukaemia masquerading as a backache
The Internet Journal of Orthopedic Surgery, 10/12/09    Relevance Score: 81%

Today in Leukemia/Lymphoma...keeping you current

Evaluation of childhood acute leukemia incidence and underreporting in Brazil by capture-recapture methodology
Cancer Epidemiology, 12/08/09

Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09

New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address